
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a veterinarian's order for one animal patient. Not FDA-approved.
No FDA-approved animal drug contains pentoxifylline; Animal Drugs@FDA returns no pentoxifylline products. Pentoxifylline is an FDA-approved human medicine. The TRENTAL extended-release tablet label describes it as a xanthine derivative indicated for intermittent claudication caused by chronic occlusive arterial disease of the limbs in people. The Merck Veterinary Manual says it has been used in limited numbers of animals for conditions including vasculitis, canine familial dermatomyositis, ear margin dermatosis and atopic dermatitis. These are not FDA-approved uses in animals. Compounded preparations are not FDA-approved and are dispensed only on a veterinarian's prescription for an individual animal.
The Merck Veterinary Manual notes stomach and intestinal side effects, such as nausea and vomiting, in animals. The human TRENTAL label says not to use it in patients with recent bleeding in the brain or retina, or in patients who have not tolerated it or related methylxanthines such as caffeine, theophylline and theobromine. The label adds that bleeding has been reported in people with or without blood thinners, antiplatelet drugs or NSAIDs, that it can raise blood levels of theophylline, and that cimetidine and some antibiotics and antidepressants can raise pentoxifylline levels. Tell your veterinarian if your animal has a bleeding problem or takes a blood thinner. Ask your veterinarian or pharmacist about other medicines and supplements your animal takes.
With no approved animal product, pentoxifylline use in animals is extralabel use of an approved human drug, permitted in nonfood-producing animal practice under 21 CFR 530.30 except when public health is threatened; compounding from an approved human product falls under 530.13(b), and 530.13(a) states that part 530 does not permit compounding from bulk drugs. Pentoxifylline is not on FDA's GFI #256 office stock list; FDA lists it as currently under review for dogs, cats and horses (both lists updated 10/05/2026). Merck describes rheologic and immunologic effects, including increased red and white cell deformability and reduced monocyte TNF-alpha production.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth